CDx - Cleveland Diagnostics was formed by Analiza DX and The Cleveland Clinic - a world leader in medical services and research - with the goals of applying Analiza`s patented platform technology to redefine cancer detection, diagnosis, progression, and prognosis. Its first product, the prostate cancer test, is expected to be in the market soon, followed by breast and ovarian cancer tests.
